UEA breakthrough could protect against breast cancer progression

Published by  Communications

On 15th Sep 2021

Leading scientists have identified a possible link between antibiotic use and the speed of breast cancer growth in mice, and identified a type of immune cell that could be targeted to reverse it.

In a new study funded by Breast Cancer Now, researchers from UEA and the Quadram Institute found that treating mice with broad-spectrum antibiotics increased the rate at which breast cancer tumours grew in them.

They also observed an increase in the size of secondary tumours that grew in other organs when the cancer spread.

Led by Dr Stephen Robinson, Group Leader at the Quadram Institute and Research Leader at UEA, the team used a cocktail of five antibiotics, and broad-spectrum antibiotic cefalexin on its own, to investigate how disrupting a healthy balance of bacteria in the gut affected breast cancer growth in mice.

The researchers discovered that the use of antibiotics led to the loss of a beneficial bacterial species, which in turn sped up tumour growth.

Through further investigation, the team also found that a type of immune cell, known as mast cells, were found in larger numbers in breast cancer tumours in mice treated with antibiotics. Blocking the function of these cells also reversed the effect of antibiotics and reduced the aggressive growth of the tumours.

It is hoped that these results could lead to a refinement of antibiotic use in people affected by breast cancer, and the development of new ways to counteract the negative effects that certain antibiotics could have on breast cancer.

This is important as while chemotherapy is a cornerstone of breast cancer treatment it reduces the number of white blood cells in the blood, making people more susceptible to infection. Antibiotics are therefore often prescribed to breast cancer patients to control any infections that arise during chemotherapy treatment.

Dr Stephen Robinson, Group Leader at the Quadram Institute and Research Leader at UEA’s School of Biological Sciences, said: “With the rise in bacteria resistance to antibiotics we have known for many years that we need to be very careful about clinical antibiotic use.

“This research further demonstrates the important role a healthy gut microbiota plays in regulating the body’s response to disease and that antibiotics play a significant role in unbalancing a healthy gut microbiome.

“Our research has shown that losing ‘good’ bacteria in the gut, as the result of antibiotic use, can lead to an increased rate of breast cancer growth.

“We believe there is a complex immune element to this mechanism involving mast cells, a type of cell whose role in many cancers is not yet fully understood. Therefore, future studies will focus on understanding the possible role of these cells as well as looking into the effects of introducing probiotics into the experimental models we use.”

Breast cancer is the most common cancer in women in the UK, with around 55,000 women and 370 men being diagnosed in the UK each year. Secondary (or metastatic) breast cancer occurs when primary breast cancer cells spread from the breast, through the lymphatic or blood system to other parts of the body.

It is not currently known how many people have secondary breast cancer, but it is estimated that 35,000 people in the UK are living with this devastating incurable disease, and the fear and uncertainty of when it will cut their lives short.

In this new research, published in iScience, Dr Stephen Robinson and PhD student Alastair McKee discovered that breast tumours grew faster in mice that were given antibiotics, compared to mice that didn’t receive antibiotic treatment. This effect was observed in mice models of the disease representing several different types of breast cancer.

The team further investigated the changes that treatment with antibiotics leads to and noticed that mice that were treated with antibiotics had an increased number of mast cells in breast tumours.

The researchers found that cromolyn, a substance that stops mast cells from working and is used to treat some other health conditions, reduced tumour growth in the antibiotic-treated mice, but not in the control group. This provides evidence that mast cells could be involved in the faster growth of breast cancer that arises from antibiotic use.

Researchers will now investigate further to understand where the increase of mast cells comes from, and why the disruption of the gut bacteria causes an increase in mast calls.

In the future, patients who need to take broad-spectrum antibiotic treatment could also be given treatments that block this negative effect of antibiotics to stop the growth of breast cancer whilst also ensuring that people are protected from chemotherapy-induced infections. It could also be possible to identify which antibiotics have the least impact on breast cancer progression.

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “One woman is diagnosed with breast cancer every 10 minutes in the UK and we urgently need to find new ways to treat patients and prevent more people dying from this devastating disease. This cutting-edge research gives us vital new knowledge into how breast cancer tumours can grow.

“Whilst the link between antibiotics and breast cancer growth may sound alarming, we want to remind everyone affected by breast cancer that this is early stage research that has currently only been tested in mice. Much more work is needed to understand the complex relationship between gut bacteria and breast cancer. However, this research does provide crucial insight and we must now further investigate the effect of antibiotics in breast cancer treatment so that we can find the best way to stop tumours from growing. Excitingly, this research has already highlighted that by targeting mast cells, we could potentially halt antibiotic-induced breast cancer growth. 

“We’re proud to have funded this research, especially at a time when the COVID-19 pandemic has profoundly impacted our world-class research - we’ve been less able to fund new research that could transform the lives of people affected by breast cancer. This is why your support is more critical now than ever before in helping us to continue to bring hope for the future through our research.” 

For more information and to donate visit www.breastcancernow.org/donate.

Breast Cancer Now is grateful to Asda Tickled Pink for their generous financial support of Dr Robinson’s project.

Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth’ is published in the journal iScience.

Study with us

Explore our research

Latest News

  News

Common antidepressant should no longer be used to treat dementia 

A drug used to treat agitation in people with dementia is no more effective than a placebo.

Read more >
  News
Tall rainforest trees
18 Oct 2021

Dr Nem Vaughan awarded Philip Leverhulme prize

The prestigious award recognises outstanding researchers.

Read more >
  News
Ziggurats and trees on UEA campus
15 Oct 2021

UEA’s great outdoors celebrated for a fifth straight year with international Green Flag award

The last 18 months have placed more value on green spaces than ever, and students arriving at the University of East Anglia (UEA) for the new academic year can...

Read more >
  News
Power station chimney emitting smoke
12 Oct 2021

How recovery from COVID-19’s impact on energy demand could help meet climate targets

New research examines different scenarios of energy-related demand and how they could impact climate mitigation targets.

Read more >
Are you searching for something?
  News
Power station chimney emitting smoke
12 Oct 2021

How recovery from COVID-19’s impact on energy demand could help meet climate targets

New research examines different scenarios of energy-related demand and how they could impact climate mitigation targets.

Read more >
  News
House in Brazilian Amazonia.
07 Oct 2021

Study reveals impact of wild meat consumption on greenhouse gas emissions

Consuming sustainably sourced wild meat instead of domesticated livestock reduces greenhouse gas emissions.

Read more >
  News
29 Sep 2021

Could Vitamin-A bring back your sense of smell after Covid?

Researchers at the University of East Anglia and James Paget University Hospital are launching a new project to see whether Vitamin A could help people regain...

Read more >
  News
27 Sep 2021

Children who eat more fruit and veg have better mental health

Children who eat a better diet, packed with fruit and vegetables, have better mental wellbeing – according to new research from the University of East Anglia...

Read more >
  News
25 Sep 2021

How rabbits help restore unique habitats for rare species

European wild rabbits are a ‘keystone species’ that hold together entire ecosystems – according to researchers at the University of East Anglia.

Read more >
  News
24 Sep 2021

Ageing the unageable: UEA researchers develop new way to age lobsters

Scientists at the University of East Anglia (UEA) have identified a way of determining the age of a lobster based on its DNA.

Read more >